baber/WOPTO huggingface dataset:
Patent NZ-520499-A (NZ)
Title: Biological data visualisation system and method
Inventor: CARDNO PAUL
IPC: G16H40/67
Filed: 2002-08-01
Abstract: A biological data visualization system comprises a plurality of data values maintained in computer memory, the data values representing biological parameter values relating to one or more patients, a value calculator configured to generate a set of differential data values representing the difference between measured biological parameter values for a patient and benchmark values for a plurality of biological parameters, a visualization component configured to generate a representation including one or more data points, each data point corresponding to a biological parameter having associated differential data values calculated for a patient, a display configured to display the representation generated by the visualization component and a contour generator configured to generate one or more contour lines and display them on the display around at least one of the data points in the representation.
Patent NZ-520717-A (NZ)
Title: Method for producing a liquid dispersion substantially containing submicron sized metal particles including nickel, mixing metal-carbonyl gas mixture via liquid bath
Inventor: WASMUND ERIC BAIN
IPC: B22F1/0545
Filed: 2001-10-05
Abstract: A method for producing a liquid dispersion containing submicron metal particles, the method comprising: a) providing a liquid bath in a vessel; b) mixing a metal- carbonyl gas with an inert carrier gas to form a metal- carbonyl gas mixture; c) introducing the metal-carbonyl gas mixture into the liquid bath; d) bubbling the metal- carbonyl gas mixture through the liquid bath; d) bubbling the metal-carbonyl gas mixture through the liquid bath; e) causing at least a portion of the metal carbonyl gas to decompose within the liquid bath to form metal particles of predetermined size and remain therein; and f) forming the liquid dispersion of metal particles in the liquid bath with a predetermined viscosity.
Patent NZ-523546-A (NZ)
Title: Stable pharmaceutical compositions of gabapentin having PH within the range 6.8 to 7.3 comprising less than 0.5% by weight of a corresponding lactum
Inventor: SINGER CLAUDE
IPC: A61K9/32
Filed: 2001-06-15
Abstract: Pharmaceutical compositions comprising gabapentin are described, wherein the gabapentin initially comprises less than 0.5% of a corresponding lactam by weight and pH in the range of 6.8 to 7.3 which after one year of storage at 25oC and 60% relative humidity the conversion of gabapentin to the corresponding lactam is in an amount of at most 0.2% by weight of gabapentin. Also described is a gabapentin comprising less than 0.5% of a corresponding lactam by weight and between 20 and 100 ppm of a mineral anion which after one year of storage at 25oC and 60% relative humidity the conversion of gabapentin to the corresponding lactam is in an amount of at most 0.2% by weight of gabapentin. The compositions are preferably in the form of a tablet.
Patent NZ-523896-A (NZ)
Title: Inhalation device with dislodging means operative on relative rotation of opposed surfaces
Inventor: ANDERSSON JAN
IPC: A61M11/00
Filed: 1998-03-13
Abstract: The inhaler has a dislodging member 141 which is typically a scraper or a brush fixed to an upper portion of the mouthpiece. Rotation of this portion dislodges any powder that has accumulated on a lower surface of a lower portion of the mouthpiece.
Patent NZ-525966-A (NZ)
Title: Battery cell tray assembly and system
Inventor: VUTETAKIS DAVID G
IPC: H01M50/112
Filed: 2001-11-15
Abstract: Here is disclosed a battery system (100) for battery powered vehicles which utilize valve-regulated, lead-acid cells (115), each cell being of the type that includes multiple positive and negative plates with separators there between assembled in a separate casing having exterior terminals (120, 122) outside the casing whereby the cells may be electrically interconnected. The flexible walls of the cells bulge outwardly when initially filled with electrolyte and uncompressed. The system includes a battery housing (100) having at least one restraint (230) extending horizontally between and attached to the side walls of the housing for preventing the bowing thereof, the restraint dividing the housing into at least two sections.
Patent NZ-526136-A (NZ)
Title: Stable suspension of insulin suspended in ethanol for aerosol delivery to the lungs
Inventor: COWAN SIU MAN L
IPC: A61K9/00
Filed: 2001-11-30
Abstract: Stable suspensions of a biologically active protein are disclosed that are suited for aerosol delivery to the lungs of a patient in need of treatment, which comprise particles of biologically active protein suspended in ethanol. Particularly disclosed is a stable suspension of insulin useful for aerosol delivery to the lungs of a patient in need of treatment comprising particles of a pharmaceutically effective amount of insulin suspended in ethanol. A method of delivering a therapeutically effective amount of a protein to the respiratory tract of a patient is described which comprises producing an aerosol of a stable liquid suspension of a protein using an electrohydrodynamic spraying means wherein the liquid suspension comprises particles of the protein suspended in ethanol. The stable ethanol suspensions of the invention may optionally contain up to about 20 % (V/V) of a pharmaceutically acceptable formulation additive such as glycerol, propylene glycol and polyethylene glycol as well as minor amounts (from about 0.05 % to about 5.0 % (W/V) of a pharmaceutically acceptable excipient.
Patent NZ-532863-A (NZ)
Title: Thymosin augmentation of genetic immunization for the treatment of hepatitis C
Inventor: WANDS JACK R
IPC: A61K48/00
Filed: 2002-10-28
Abstract: A pharmaceutical combination comprising a polynucleotide comprising one or more hepatitis C virus peptides and one or more alpha thymosins is useful for enhancing the immune response when immunizing a subject susceptible to hepatitis C virus infection.
Patent NZ-535795-A (NZ)
Title: A method of tracing an animal product to its system or farm of origin
Inventor: PLASTOW GRAHAM S
IPC: C12N15/09
Filed: 2003-04-08
Abstract: A method of tracing an animal product to its system or farm of origin comprising: i) obtaining a sample of the animal product; ii) genotyping the animal product utilizing a DNA marker based system to obtain genotyping information; iii) comparing the genotyping information of the animal product to a reference database which comprises DNA marker profiles of related animals unique to different systems or farms; iv) analyzing the genotyping information with the reference database to determine a system or farm of origin for the product.
Patent NZ-537188-A (NZ)
Title: Tangential flow filtration devices and methods for leukocyte enrichment
Inventor: BOSCH MARNIX L
IPC: C12N5/0789
Filed: 2003-06-19
Abstract: Disclosed are tangential flow filtration devices and methods for enriching a heterogeneous mixture of blood constituents for leukocytes by removal of non-leukocyte blood constituents. In one particular embodiment the device can provide a composition enriched in monocytes. One embodiment includes a remover unit (1) having a crossflow chamber (3) separated by a microporous filter (5) from a filtrate chamber (4), the remover unit (1) also having a tangential flow inlet (6), a fluid outlet (7) for a fluid enriched in leukocytes and a filtrate outlet (8).
Patent NZ-539409-A (NZ)
Title: Method and apparatus for control of an electric power system in response to circuit abnormalities
Inventor: NELSON WILLIAM CHRISTIAN TRACY
IPC: G05D9/00
Filed: 2003-10-17
Abstract: A methodology for allocating system resources in an electrical power system that has a plurality of defined nodes at points in the electrical power system is disclosed. The methodology allocates system resources via resources at each node for determining resource allocation requirements and communications of source allocation messages to other nodes to request and establish an appropriate allocation of system resources. The source allocation messages include information representing a request for source allocation evaluation and reservation. The allocation of system resources includes the prevention of overloading of system power sources.
Patent NZ-541718-A (NZ)
Title: Methods and materials for nanocrystalline surface coatings and attachment of peptide amphiphile nanofibers thereon
Inventor: STUPP SAMUEL I
IPC: A61F2/00
Filed: 2004-02-11
Abstract: Disclosed is a nanotextured biocompatible composite, comprising a biocompatible substrate, a calcium phosphate component on such said substrate; and a nanocrystalline mineral phase on said calcium phosphate component, said mineral phase comprising calcium phosphate and poly (L-lysine).
Patent NZ-550707-A (NZ)
Title: Peptidic vasopressin receptor agonists
Inventor: WISNIEWSKI KAZIMIERZ
IPC: A61K38/00
Filed: 2005-08-03
Abstract: Disclosed is a compound of formula (I), or a solvate or pharmaceutically acceptable salve thereof, wherein Ar is aromatic ring, either carbocyclic or heterocyclic, as described, m is 1-3, n is 0-4, p is 2-4, and wherein the other substituents are as defined in the specification. Also disclosed is the use of the compounds for treating shock of hypovolemic or vasodilatory origin, bleeding esophageal varices, hepatorenal syndrome, cardiopulmonary resuscitation, anesthesia-induced hypotension, orthostatic hypotension, paracentesis-induced circulatory dysfunction, intra-operative blood loss or blood loss associated with bum debridement and epistaxis, or various ocular diseases.
Patent NZ-562951-A (NZ)
Title: Cancer treatment using a Newcastle disease virus, a fluoropyrimidine and a camptothecin combination
Inventor: LORENCE ROBERT M
IPC: C07K5/00
Filed: 2006-07-12
Abstract: Disclosed the use of a Newcastle disease virus, a fluoropyrimidine, and a camptothecin compound in the manufacture of a medicament for treating a subject having a neoplasm. Also disclosed is a method of treating a non-human mammalian subject having a neoplasm, comprising administering to the subject a Newcastle disease virus, a fluoropyrimidine, and a camptothecin compound in one or more cycles in a combined amount effective to treat the subject.
Patent NZ-565311-A (NZ)
Title: Anti-ctla-4 antibody and cpg-motif-containing synthetic oligodeoxynucleotide combination therapy for cancer treatment
Inventor: READETT DAVID ROBERT JOHN
IPC: A61K31/7088
Filed: 2006-06-30
Abstract: Disclosed is the use of a therapeutically effective amount of an anti-CTLA-4 antibody, or antigen-binding portion thereof, in combination with a therapeutically effective amount of CpG ODN PF3512676 (SEQ ID NO: 37 for the manufacture of a medicament for the treatment of cancer.
Patent NZ-569976-A (NZ)
Title: Determination of apnea/hypopnea during CPAP treatment
Inventor: ALDER MATTHEW
IPC: A62B7/00
Filed: 2007-03-06
Abstract: Controllable continuous positive airway pressure delivery (CPAP) treatment apparatus is disclosed having a controllable flow generator (34, 38, 40) operable to produce breathable gas at a treatment pressure elevated above atmosphere to a patient by a delivery tube (32) coupled to a mask (30) having connection with a patient's airway. A sensor (44, 50, 56, 58) generates a signal representative of patient respiratory flow, that is provided to a controller (54, 62, 64). The controller (54, 62, 64) is operable to determine the occurrence of an apnea/hypopnea from a comparison of a threshold based upon long term ventilation with short term ventilation, and if an apnea/hyponea is detected, increasing the treatment pressure during the occurrence of the appnea/hyponea.
Patent NZ-571742-A (NZ)
Title: Microlens windows and interphased images for packaging and printing and methods for manufacture
Inventor: KARSZES WILLIAM M
IPC: B65D5/42
Filed: 2007-04-02
Abstract: The present microlens for packaging and printing includes a package including a body; and a microlens window located on the body to display at least one graphical image in a first portion of the microlens window and the contents of the package through a second portion of the microlens window.
Patent NZ-572605-A (NZ)
Title: Transport unit and method of manufacture thereof
Inventor: MANSSON EVERT
IPC: B65B13/02
Filed: 2007-05-04
Abstract: A transport unit 20 comprising a EURO pallet 10 with a flat load surface, a load 30 which comprises at least one coil 1 of a web 3 of interconnected container blanks 2 wound on a reel 6 and having a lower surface 22 resting on the pallet, a load distributing element 18, and a tightening strap 50, with the load 30 being carried by the pallet 10 in such a manner that the reel 6 of the coil 1 is arranged perpendicular to the pallet 10. The load 30 has an upper surface 21 facing the load distributing element 18. The lower face of the load comprises an end face 25 of the reel 6 of the coil and a bottom surface 23 formed of a bottom edge 24 of the web 3. The tightening strap 50 encloses a force-absorbing structure 40 formed by the pallet 10, the reel 6 and the load distributing element 18 and is adapted to secure the load to the pallet. The transport unit allows the transport of multiple coils.
Patent NZ-575538-A (NZ)
Title: Novel benzofuran type derivatives, a composition comprising the same for treating or preventing cognitive dysfunction and the use thereof
Inventor: KANG DONG WOOK
IPC: C07D307/80
Filed: 2007-10-02
Abstract: Disclosed are Benzofuran type derivatives represented by a compound of formula (I), wherein the substituents are as defined in the specification. The compounds are useful in the treatment or prevention of cognitive function disorder by inhibiting accumulated beta-amyloid.
Patent NZ-578977-A (NZ)
Title: 2-aminopyrimidine modulators of the histamine h4 receptor
Inventor: CAI HUI
IPC: A01N43/40
Filed: 2008-02-14
Abstract: Provided is a 2-aminopyrimidine modulator of histamine H4 receptor with the compound formula (I) with specified substituents. The compound can be used to treat a variety of diseases, including allergy, asthma, and other immunological disorders.
Patent NZ-581989-A (NZ)
Title: Sirtuin modulating imidazothiazole compounds
Inventor: BEMIS JEAN
IPC: A61K31/426
Filed: 2008-06-20
Abstract: Disclosed is a sirtuin-modulating compound, or salt thereof, of formula III, wherein: R is -H or -CH3; R1 is a substituted or unsubstituted nitrogen-containing heterocyclylmethyl group; R2 is -H or CH3; and R3 is an unsubstituted pyridyl group. Further disclosed is a pharmaceutical composition comprising a compound of formula III, and the use of a compound of formula III for use in the manufacture of a medicament for treating or preventing insulin resistance, a metabolic syndrome, diabetes, or complications thereof, or for increasing insulin sensitivity in a subject.
Patent NZ-585761-A (NZ)
Title: Aerodynamic wind propulsion device having active and passive steering lines and method for controlling of such a device
Inventor: WRAGE STEPHAN
IPC: B63B35/79
Filed: 2007-12-19
Abstract: Disclosed is an aerodynamic wind propulsion device, particularly for watercrafts, comprising an aerodynamic wing being connected to a steering unit located below the aerodynamic wing via a plurality of tractive lines (105a, 105b, 106a, 106b), at least one pair of two active steering lines being connected to the aerodynamic wing at two points in distance and being coupled to a drive unit at the steering unit, a tractive cable, a first end of the tractive cable being connected at the steering unit (100) to at least two of the tractive lines and a second end of the tractive cable being connected to a base platform, the aerodynamic wing having an aerodynamic profile which generates an uplift force, a pair of two passive steering lines (103a, 103b), wherein each of the two passive steering lines comprises a lower section and an upper section, wherein a second end of the lower section of each passive steering line is connected to a first end of the upper section of the respective passive steering line via a connecting member (151a, 151b). A further aspect is related to a method for controlling an aerodynamic wind propulsion device.
Patent NZ-588369-A (NZ)
Title: Improved formulations for poorly permeable active pharmaceutical ingredients
Inventor: MOSCHWITZER JAN P
IPC: A61K9/28
Filed: 2009-04-21
Abstract: Disclosed is a thermostable solid composition comprising at least one permeability improving substance selected from the group consisting of: polyethylene glycol, propylene glycol, glycerin, an oil, glycofurol, propylene glycol dicaprylate or dicaprate, glyceryl caprylate or caprate, oleic acid, ethoxydiglycol, and poloxamer block copolymers, polysorbates, sorbitan esters, poloxamer block copolymers, hydrogenated castor oil, caprylocaproyl macrogol-8 glycerides, sodium lauryl sulfate, dioctyl sulfosuccinate, polyethylene lauryl ether, ethoxydiglycol, propylene glycol monocaprylate, propylene glycol mono-di-caprylate, propylene glycol dicarpylate or dicparate, glyceryl monocaprylate, glyceryl mono-di-caprylate, caprylocaproyl macrogolglycerides like PEG caprylic or capric glycerides, glyceryl 15 fatty acids (C8 -C18) ethoxylated, oleic acid, linoleic acid, glyceryl monooleate, glyceryl monolaurate, caprylic or capric triglycerides, ethoxylated nonylphenols, lecithin, said permeability improving substance(s) being embedded in a water soluble matrix, with the proviso that said thermostable solid composition does not contain an active pharmaceutical ingredient. Pharmaceutical compositions comprising two phases wherein one phase comprises an active ingredient and the other phase comprises the thermostable solid composition are also disclosed.
Patent NZ-589811-A (NZ)
Title: A gasification burner with a pilot burner where the medium in the burner pipe space can be changed after ignition of the pilot burner
Inventor: KUSKE EBERHARD
IPC: C01B3/36
Filed: 2009-07-07
Abstract: A device 1 comprises a pilot burner 2 positioned in the centre of a gasification burner 15, the pilot burner 2 being equipped with a centric nozzle head 3 arranged to supply a fuel gas in a flow direction, a burner pipe projecting beyond the nozzle head 3 in the flow direction and defining a burner pipe space 8, and at least one electrical ignition device 9 provided within the burner pipe space 8. The burner pipe space 8 reduces in cross-section downstream of the electrical ignition device 9, and the medium in the burner pipe space 8 can be changed after ignition of the gasification burner 15.
Patent NZ-591315-A (NZ)
Title: 2-oxo-1,2-dihydro-quinoline modulators of immune function
Inventor: GANT THOMAS G
IPC: A61P37/08
Filed: 2009-09-02
Abstract: Disclosed is a 2-oxo-1,2-dihydro-quinoline (also known as Laquinimod) compound of formula I, wherein the substituents are independently selected from the group consisting of hydrogen and deuterium, and where at least one substituent is deuterium. Further disclosed is a pharmaceutical composition comprising said compound, and the use of said compound in the manufacture of a medicament for use in treating an immune function mediated disorder.
Patent NZ-599354-A (NZ)
Title: Water purification apparatus comprising an uv source
Inventor: KIM HEUNG SOON
IPC: C02F1/32
Filed: 2010-10-26
Abstract: 593354 A purification apparatus, comprises an elongate UV source and a conduit for water, or another fluid, to be purified, the conduit being formed of a UV transmissive material, wherein the conduit has an inlet and an outlet and is positioned so that part of it is wrapped around at least part of the UV source thereby to sterilise water or fluid within the conduit. The apparatus further comprises reflective means for causing UV radiation to be reflected onto one or more parts of the conduit which extends beyond the part which is wrapped around the UV source. The reflective means comprises a cap 40 having a surface adapted to reflect UV radiation to a part of the conduit which is not wrapped around the UV source, and the cap 40 has at least one refelctive internal surface arranged to reflect UV radiation to the end of the outlet of the conduit
Patent NZ-600417-A (NZ)
Title: Hair styling attachment
Inventor: COHEN GIDON
IPC: A45D20/12
Filed: 2010-10-28
Abstract: A hair dryer (110), or blower, for use in straightening or styling hair with a round hair brush (120), is disclosed. The hair dryer comprises a hot air outlet through which air is blown, an air inlet for sucking in air at room temperature, an attachment (112) to the hot air outlet comprising a heat conducting device terminating in a flat elongated nozzle, and an attachment (116) to the air inlet. When the dryer is turned on to blow hot air through the outlet, the hot air passes over the heat conducting device raising the temperature such that when the edge of the nozzle is drawn over wet hair that is being shaped with a hair brush the hair is fixed in the shaped condition due to the drying at a higher temperature. The attachment to the air inlet has a shape complementary to the curvature of a round hair brush (120) used in shaping the hair. In use, the attachment to the inlet is brought in direct contact with the hair on the round brush as the ambient temperature air is sucked through the hair and brush at high volume and maximum force.
Patent NZ-617916-A (NZ)
Title: Method for producing chiral 8-(3-amino-piperidin-1-yl)-xanthines
Inventor: PFRENGLE WALDEMAR
IPC: C07D473/04
Filed: 2005-11-02
Abstract: Disclosed is a process for preparing a medicament comprising using an 8-(3-aminopiperidin-1-yl)xanthine of the general formula (I) or an enantiomer or salt thereof, wherein the substituents are as defined in the specification, comprising the following synthesis steps: a) reaction of a compound of the general formula (III) in which X is a leaving group selected from the group of halogens or sulphonic esters,with 3-(phthalimido)piperidine of formula (IV) or an enantiomer thereof, b) deprotection of the thus obtained compound of the general formula (II) and c) optional conversion to a physiologically tolerated salt and one or more carrier and diluents. Also disclosed are the enantiomers (R)-3-(phthalimido)piperidine and (S)-3- (phthalimido)piperidine and processes for their preparation. (R)-3-(phthalimido)piperidine is a particularly preferred reactant in the process for preparing compounds of formula (I).
Patent NZ-621321-A (NZ)
Title: Use of omega fatty acids for treating disease
Inventor: GEORGIOU TASSOS
IPC: A61P27/02
Filed: 2012-09-12
Abstract: Provided is a combination of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) formulated for use in the treatment and/or prophylaxis of a condition selected from macular oedema, conditions causing damage to retinal photoreceptors and/or retinal pigment epithelial cells, and dry eyes in a mammal, wherein the combined dosage of EPA and DHA is from 5 mmol to 25 mmol per day, and wherein the molar ratio of EPA to DHA is in the range of from 1:1 to 5: 1.
Patent NZ-626188-A (NZ)
Title: Chimeric therapeutic anti - cd37 antibody hh1
Inventor: LARSEN ROY H
IPC: C07K16/28
Filed: 2012-12-12
Abstract: The present invention relates an antibody molecule that binds to human CD37 and that is a chimeric antibody wherein the variable sequences are: a variable heavy chain comprising the amino acid sequence shown in SEQ ID NO: 1; and a variable light chain comprising the amino acid sequence shown in SEQ ID NO :3 (sequences as defined within the specification).